| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $642K | -71.7% |
| Cost of Revenue | $164K | -92.3% |
| R&D Expense | $30.3M | -0.6% |
| SG&A Expense | $20.5M | -40.6% |
| Operating Income | -$50.5M | +25.0% |
| Interest Expense | $15.3M | +4.6% |
| Income Tax | $0 | — |
| Net Income | -$69.9M | -17.3% |
| EPS (Basic) | -$5.73 | +75.6% |
| EPS (Diluted) | -$5.73 | +75.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.4M | -4.8% |
| Accounts Receivable | $233K | +77.9% |
| Inventory | $722K | +6.3% |
| Current Assets | $44.7M | +19.5% |
| Total Assets | $44.9M | +17.2% |
| Current Liabilities | $53.9M | +142.5% |
| Long-term Debt | $109.6M | +6.9% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.6M | +20.0% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $56.5M | +54.2% |
| Free Cash Flow | -$57.6M | +20.0% |
| $140.4M |
| +6.8% |
| Stockholders' Equity | -$95.5M | -2.5% |